Modifications on the basic skeletons of vinblastine and vincristine

Molecules

Volumn 17, Issue 5, 2012, Pages 5893-5914

  Keglevich, Péter ^a   Hazai, László ^a   Kalaus, György ^a   Szántay, Csaba ^a  

^a BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

Author keywords

Antitumor therapy; Derivatives; Vinblastine; Vincristine

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; VINBLASTINE; VINCRISTINE; VINDOLINE;

CHEMISTRY; OXIDATIVE COUPLING; REVIEW;

ANTINEOPLASTIC AGENTS; OXIDATIVE COUPLING; VINBLASTINE; VINCRISTINE;

EID: 84861488421     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17055893     Document Type: Review

References (47)

1. Brossi, A., Suffness, M., Eds. Antitumor Bisindol Alkaloids from Catharanthus Roseus (L.). In The Alkaloids; Academic Press Inc.: New York, NY, USA, 1990; Volume 37, pp. 1-240.
2. Bölcskei, H.; Szabó, L.; Szántay, C. Synthesis of vinblastine derivatives. Front. Nat. Prod. Chem. 2005, 1, 43-49.
3. Eli Lilly Company, Neue Aminderivate von Vinblastin, Leurosidin und Leurocristin und Verfahren zu ihrer Herstellung. DE Patent 22415980, 1974; [Chem. Abstr. 1974, 82, 579967b].
4. Barnett, C.J.; Cullinan, G.J.; Gerzon, K.; Hoying, R.C.; Jones, W.E.; Newlon, W.M.; Poore, G.A.; Robison, R.L.; Sweeney, M.J.; Todd, G.C. Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate. J. Med. Chem. 1978, 21, 88-96.
5. Thimmaiah, K.N.; Lloyd, W.D.; Sethi, V.S. A simple method for the chemical modification of antitumor Catharanthus Vinca alkaloids. Ind. J. Chem. Sect. B: Org. Chem. Med. Chem. 1990, 29, 678-680.
6. Brady, S.F.; Pawluczyk, J.M.; Lumma, P.K.; Feng, D.-M.; Wai, J.M.; Jones, R.; DeFeo-Jones, D.; Wong, B.K.; Miller-Stein, C.; Lin, J.H.; et al. Design and synthesis of a pro-drug of vinblastine targeted at treatment of prostate cancer with enhanced efficacy and reduced systemic toxicity. J. Med. Chem. 2002, 45, 4706-4715.
7. Scott, I.L.; Ralph, J.M.; Voss, M.E. Vinca derivatives. WO Patent 2005/55939, 2005.
8. Voss, M.E.; Ralph, J.M.; Xie, D.; Manning, D.D.; Chen, X.; Frank, A.J.; Leyhane, A.J.; Liu, L.; Stevens, J.M.; Budde, C.; et al. Synthesis and SAR of Vinca alkaloid analogues. Bioorg. Med. Chem. Lett. 2009, 19, 1245-1249.
9. Lafitte, C.; Jouannetaud, M.-P.; Jacquesy, J.-C.; Fahy, J.; Duflos, A. Stereoselective ionic hydrogenation of Vinca alkaloids and vinorelbine in Superacids: An access to 4'R-reduced analogs. Tetrahedron Lett. 1998, 39, 8281-8282.
10. Fahy, J.; Duflos, A.; Ribet, J.-P.; Jacquesy, J.-C.; Berrier, C.; Jouannetaud, M.-P.; Zunino, F. Vinca alkaloids in superacid media: A method for creating a new family of antitumor derivatives. J. Am. Chem. Soc. 1997, 119, 8576-8577.
11. Bölcskei, H.; Szántay, C., Jr.; Mák, M.; Balázs, M.; Szántay, C. New antitumor derivatives of vinblastine (in Hungarian). Acta Pharm. Hung. 1998, 68, 87-93.
12. Szabó, L.; Bölcskei, H.; Baitz-Gács, E.; Mák, M.; Szántay, C. Synthesis of Vinca alkaloids and related compounds, part XCVI. Nitration study of vinblastine-type bisindole alkaloids. Arch. Pharm. (Weinheim, Germany) 2001, 334, 399-405.
13. Szabó, L.; Szántay, C.; Gács-Baitz, E.; Mák, M. Synthesis of Vinca alkaloids and related compounds. LXXVIII. A potentionally biologically useful reduction of nitro-vincristine. Tetrahedron Lett. 1995, 36, 5265-5266.
14. Rao, K.S.P.B.; Collard, M.-P.M.; Dejonghe, J.P.C.; Atassi, G.; Hannart, J.A.; Trouet, A. Vinblastin-23-oyl amino acid derivatives: Chemistry, physicochemical data, toxicity, and antitumor activities against P388 and L1210 leukemias. J. Med. Chem. 1985, 28, 1079-1088.
15. Hendriks, H.R.; Langdon, S.; Berger, D.P.; Breistol, K.; Fiebig, H.H.; Fodstad, O.; Schwartsmann, G. Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts. Eur. J. Cancer 1992, 28, 767-773.
16. Bánóczi, Z.; Gorka-Kereskényi, Á.; Reményi, J.; Orbán, E.; Hazai, L.; Tokési, N.; Oláh, J.; Ovádi, J.; Béni, Z.; Háda, V.; et al. Synthesis and in vitro antitumor effect of vinblastine derivative-oligoarginine conjugates. Bioconjug. Chem. 2010, 21, 1948-1955.
17. Ngo, Q.A.; Roussi, F.; Cormier, A.; Thoret, S.; Knossow, M.; Guénard, D.; Guéritte, F. Synthesis and biological evaluation of Vinca alkaloids and phomopsin hybrids. J. Med. Chem. 2009, 52, 134-142.
18. Trédaniel, J.; Staudacher, L.; Teixeira, L.; Sebbagh, S.; Bucquet, S.; Hennequin, C. Pharmacotherapy update: Vinorelbine in the treatment non-small-cell lung cancer. Clin. Med. Insights: Ther. 2010, 2, 179-188.
19. Passrella, D.; Giardini, A.; Peretto, B.; Fontana, G.; Sacchetti, A.; Silvani, A.; Ronchi, C.; Cappalletti, G.; Cartelli, D.; Borlak, J.; et al. Inhibitors of tubulin polymerization: Synthesis and biological evaluation of hybrids of vindoline, anhydrovinblastine and vinorelbine with thiocolchicine, podophyllotoxin and baccatin III. Bioorg. Med. Chem. 2008, 16, 6269-6285.
20. Vlahov, I.R.; Santhapuram, H.K.R.; Kleindl, P.J.; Howard, S.J.; Stanford, K.M.; Leamon, C.P. Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide. Bioorg. Med. Chem. Lett. 2006, 16, 5093-5096.
21. Kuehne, M.E.; Bornmann, W.G.; Markó, I.; Qin, Y.; LeBoulluec, K.L.; Frasier, D.A.; Xu, F.; Mulamba, T.; Ensinger, C.L.; Borman, L.S.; et al. Synthesis and biological evaluation of vinblastine congeners. Org. Biomol. Chem. 2003, 1, 2120-2136.
22. Honty, K.; Demeter, Á.; Szántay, C., Jr.; Hollósi, M.; Kolonits, P.; Szántay, C. Synthesis of Vinca alkaloids and related compounds. Part XCIII. Skeletal rearrangement of cyclovinblastine derivatives: Formation of a novel bisindole system. Heterocycles 1999, 50, 169-194.
23. Kutney, J.P.; Balsevich, J.; Worth, B.R. Studies on the synthesis of bisindole alkaloids. XV. A synthesis of vinamidine (catharinine). Heterocycles 1978, 11, 69-73.
24. Bornmann, W.G.; Kuehne, M.E. A common intermediate providing syntheses of ?-tabersonine, coronaridine, iboxyphylline, ibophyllidine, vinamidine, and vinblastine. J. Org. Chem. 1992, 57, 1752-1760.
25. Orosz, F.; Comin, B.; Rais, B.; Puigjaner, J.; Cascante, M.; Kovács, J.; Tárkányi, G.; Ács, T.; Keve, T.; Ovádi, J. New bis-indol derivatives: Chemical, biochemical and cellular studies. Br. J. Cancer 1999, 79, 1356-1365.
26. Bölcskei, H.; Szántay, C., Jr.; Mák, M.; Balázs, M.; Szántay, C. New antitumor hydroxymethyl derivatives of vinblastine. J. Indian Chem. Soc. 1997, 74, 904-907.
27. Szántay, C. Indole alkaloids in human medicine. Pure Appl. Chem. 1990, 62, 1299-1302.
28. Ahn, S.H.; Duffel, M.W.; Rosazza, J.P.N. Oxidations of vincristine catalyzed by peroxidase and ceruloplasmin. J. Nat. Prod. 1997, 60, 1125-1129.
29. Moisan, L.; Comesse, S.; Giovanelli, E.; Rousseau, B.; Doris, E.; Hellier, P. Fluorinated catharanthine derivatives, their preparation and their utilisation as Vinca dimeric alkaloid precursors. WO Patent 2008/034882, 2008.
30. Kruczynski, A.; Barret, J.-M.; Etiévant, C.; Colpaert, F.; Fahy, J.; Hill, B.T. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid. Biochem. Pharmacol. 1998, 55, 635-648.
31. Krzakowski, M.; Ramlau, R.; Jassem, J.; Szczesna, A.; Zatloukal, P.; Von Pawel, J.; Sun, X.; Bennoung, J.; Santoro, A.; Biesma, B.; et al. Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy. J. Clin. Oncol. 2010, 28, 2167-2173.
32. Fahy, J.; Duflos, A.; Ribet, J.-P.; Jacquesy, J.-C.; Berrier, C.; Jouannetaud, M.-P.; Zunino, F. Vinca alkaloids in superacidic media: A method for creating a new family of antitumor derivatives. J. Am. Chem. Soc. 1997, 119, 8576-8577.
33. Giovanelli, E.; Leroux, S.; Moisan, L.; Carreyre, H.; Thuéry, P.; Buisson, D.-A.; Meddour, A.; Coustard, J.-M.; Thibaudeau, S.; Rousseau, B.; et al. On the elucidation of the mechanism of Vinca alkaloid fluorination in superacidic medium. Org. Lett. 2011, 13, 4116-4119.
34. Jacquesy, J.-C.; Berrier, C.; Jouannetaud, M.-P.; Zunino, F.; Fahy, J.; Duflos, A.; Ribet, J.-P. Fluorination in superacids: A novel access to biologically active compounds. J. Fluorine Chem. 2002, 114, 139-142.
35. Andriamialisoa, R.Z.; Langlois, N.; Langlois, Y.; Potier, P. Compesés antitumoraux du groupe de la vinblastine: Nouvelle méthode de préparation. Tetrahedron 1980, 36, 3053-3060.
36. Hardouin, C.; Doris, E.; Rousseau, B.; Mioskowski, C. Selective deoxygenation of leurosine: Concise access to anhydrovinblastine. J. Org. Chem. 2002, 67, 6571-6574.
37. Potier, P. Synthesis of the antitumor dimeric indole alkaloids from Catharanthus species (vinblastine group). J. Nat. Prod. 1979, 43, 72-86.
38. Tam, A.; Gotoh, H.; Robertson, W.M.; Boger, D.L. Catharanthine C16 substituent effects on the biomimetic coupling with vindoline: Preparation and evaluation of a key series of vinblastine analogues. Bioorg. Med. Chem. Lett. 2010, 20, 6408-6410.
39. Gotoh, H.; Duncan, K.K.; Robertson, W.M.; Boger, D.L. 10'-Fluorovinblastine and 10'-fluorovincristine: Synthesis of a key series of modified Vinca alkaloids. ACS Med. Chem. Lett. 2011, 2, 948-952.
40. Gorka-Kereskényi, Á.; Szabó, L.; Hazai, L.; Lengyel, M.; Szántay, C., Jr.; Sánta, Z.; Kalaus, G.; Szántay, C. Aromatic electrophilic substitutions on vindoline. Heterocycles 2007, 71, 1553-1563.
41. Kutney, J.P.; Balsevich, J.; Honda, T.; Liao, P.-H.; Thiellier, H.P.M.; Worth, B.R. Total synthesis of indole and dihydroindole alkaloids. XVI. Derivatives of vinblastine and vincristine: Change of functionality in the vindoline unit. Can. J. Chem. 1978, 56, 2560-2566.
42. Ishikawa, H.; Colby, D.A.; Seto, S.; Va, P.; Tam, A.; Kakei, H.; Rayl, T.J.; Hwang, I.; Boger, D.L. Total synthesis of vinblastine, vincristine, related natural products, and key structural analogues. J. Am. Chem. Soc. 2009, 131, 4904-4916.
43. Noble, R.L.; Beer, T.; McIntyre, R.W. Biological effects of dihydroviblastine. Cancer 1967, 20, 885-890.
44. Shao, Y.; Ding, H.; Tang, W.; Lou, L.; Hu, L. Synthesis and structure-activity relationships study of novel anti-tumor carbamate anhydrovinblastine analogues. Bioorg. Med. Chem. 2007, 15, 5061-5075.
45. Song, W.; Lei, M.; Zhao, K.; Hu, L.; Meng, Y.; Guo, D.; Liu, X.; Hu, L. Ceric ammonium nitrate-promoted oxidative coupling reaction for the synthesis and evaluation of a series of anti-tumor amide anhydrovinblastine analogs. Bioorg. Med. Chem. Lett. 2012, 22, 387-390.
46. Va, P.; Campbell, E.L.; Robertson, W.M.; Boger, D.L. Total synthesis and evaluation of a key series of C5-substituted vinblastine derivatives. J. Am. Chem. Soc. 2010, 132, 8489-8495.
47. Sasaki, Y.; Kato, D.; Boger, L. Asymmetric total synthesis of vindorosine, vindoline, and key vinblastine analogues. J. Am. Chem. Soc. 2010, 132, 13533-13544.